FREZENT Biological Solutions is a startup based in the United States.
FREZENT Biological Solutions is a company headquartered in the United States.
FREZENT Biological Solutions develops first-in-class antibody therapies targeting dormant cancer cells to prevent cancer recurrence, initially focusing on head and neck cancer and expanding to other cancers like osteosarcoma and pancreatic cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.